InvestorsHub Logo
Followers 63
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: None

Saturday, 11/06/2021 12:50:51 AM

Saturday, November 06, 2021 12:50:51 AM

Post# of 719991
100% agree on my end too. We shouldn’t have gone this far without a partner, but that is hindsight mostly. There was opportunity before the phase IV-Cognate debacle, but according to LP the only thing BP brings to the table is money. That statement should have been my clue that we were going to go down a long and winding road of uncertainty with amatuers. BP brings so much more than money to the table, but money itself is one of the most important factors for a small start-up biotech. Another thing they bring is FDA relationships, but that is a small piece of what they bring to the table.

I love Mav’s BioNtech example. Did Pfizer just bring money to that table? Seems to me that we would be seeing at least a few hundred thousand more US deaths from COVID and an economy that may never recover if BioNtech had the same attitude LP has.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News